🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › Michigan › Ann Arbor

Qorannoo klinikaalii Kansarii Ovarii Ann Arbor, MI keessatti

Qorannoo 11 Kansarii Ovarii f Ann Arbor fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Namoota walitti qabaa jiraSadarkaa 2/3
  • University of Michigan Rogel Cancer Center, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
  • fi 6 dabalataa
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564377

A Study of PHST001 in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of Michigan Rogel Cancer Center, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06840886

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Namoota walitti qabaa jiraSadarkaa 2
  • University of Michigan Health System, Ann Arbor
Umuriin 18 hanga 99 · Dubartoota · Haaromfame 15-Ful-2026 · NCT07023627

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Namoota walitti qabaa jiraSadarkaa 3
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Dubartoota · Haaromfame 26-Hag-2026 · NCT05281471

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • C S Mott Children's Hospital, Ann Arbor
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Namoota walitti qabaa jira
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • fi 4 dabalataa
Umuriin 35 hanga 50 · Dubartoota · Haaromfame 07-Hag-2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
  • fi 6 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06580314

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Namoota walitti qabaa jiraSadarkaa 3
  • Trinity Health St. Joseph Mercy Ann Arbor, Ann Arbor
Umuriin 18 fi ol · Dubartoota · Haaromfame 02-Ado-2026 · NCT06819007

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Ann Arbor
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT05941507

Qorannoo Kansarii Ovarii magaalota biroo keessatti

Qorannoo biroo Ann Arbor keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.